| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4238941 | Journal of Vascular and Interventional Radiology | 2013 | 6 Pages |
Abstract
In DEB chemoembolization for treatment of HCC, 100-300 μm doxorubicin DEBs are favored over 300-500 μm doxorubicin DEBs because of lower rates of toxicity after treatment and a trend toward more complete imaging response at initial follow-up.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Siddharth A. MD, Giri MD, Sarah DO, Puneet MD, Nghia J. MD, Sandeep MD, Karim MD, William P. MD, Daniel S. MS, Matthew J. MD,